{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:16:59Z","timestamp":1791649019665,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejpb.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T11:53:45Z","timestamp":1686225225000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The effects of degree and duration of supersaturation on in vivo absorption profiles for highly permeable drugs, dipyridamole and ketoconazole"],"prefix":"10.1016","volume":"189","author":[{"given":"Haruki","family":"Higashino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.06.002_b0005","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1211\/0022357991772277","article-title":"Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique","volume":"51","author":"Kohri","year":"1999","journal-title":"J Pharm Pharmacol."},{"key":"10.1016\/j.ejpb.2023.06.002_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2008.09.034","article-title":"Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement","volume":"367","author":"Tao","year":"2009","journal-title":"Int J Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0020","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/mp100109a","article-title":"Quantitative analysis of the effect of supersaturation on in vivo drug absorption","volume":"7","author":"Takano","year":"2010","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0025","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s11095-008-9676-2","article-title":"Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds","volume":"25","author":"Shiraki","year":"2008","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2023.06.002_b0030","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1007\/s11095-013-1126-0","article-title":"Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion\/absorption pathway","volume":"30","author":"Williams","year":"2013","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2023.06.002_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2016.05.013","article-title":"Effectiveness of supersaturation promoting excipients on albendazole concentrations in upper gastrointestinal lumen of fasted healthy adults","volume":"91","author":"Kourentas","year":"2016","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejps.2017.02.042","article-title":"The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS)","volume":"102","author":"Tsume","year":"2017","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1018918316253","article-title":"pH-Related Changes in the Absorption of Dipyridamole in the Elderly","volume":"11","author":"Russell","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.06.002_b0050","first-page":"228","article-title":"Effect of food and gastric acidity on absorption of orally administered ketoconazole","volume":"7","author":"Lelawongs","year":"1988","journal-title":"Clin Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0055","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-114-9-755","article-title":"Increased gastric pH and the bioavailability of fluconazole and ketoconazole","volume":"114","author":"Blum","year":"1991","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ejpb.2023.06.002_b0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jps.22760","article-title":"Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms","volume":"101","author":"Ozaki","year":"2012","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0065","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/pharmaceutics13081136","article-title":"Bioequivalence of Oral Drug Products in the Healthy and Special Populations: Assessment and Prediction Using a Newly Developed In Vitro System \u201cBE Checker\u201d","volume":"13","author":"Masada","year":"2021","journal-title":"Pharmaceutics."},{"issue":"13","key":"10.1016\/j.ejpb.2023.06.002_b0070","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/cg301679h","article-title":"Liquid-Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations","volume":"13","author":"Ilevbare","year":"2013","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2023.06.002_b0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/mp500571m","article-title":"Assessment of the Amorphous \u201cSolubility\u201d of a Group of Diverse Drugs Using New Experimental and Theoretical Approaches","volume":"12","author":"Sousa","year":"2015","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0080","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.xphs.2020.04.014","article-title":"Impact of Hypromellose Acetate Succinate Grade on Drug Amorphous Solubility and In Vitro Membrane Transport","volume":"109","author":"Ueda","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/pharmaceutics13060889","article-title":"Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?","volume":"13","author":"Qian","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2023.06.002_b0090","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/acs.molpharmaceut.0c01207","article-title":"In Vitro Sensitivity Analysis of the Gastrointestinal Dissolution Profile of Weakly Basic Drugs in the Stomach-to-Intestine Fluid Changing System: Explanation for Variable Plasma Exposure after Oral Administration","volume":"18","author":"Takagi","year":"2021","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11095-012-0931-1","article-title":"Measurement of drug concentration in the stomach after intragastric administration of drug solution to healthy volunteers: Analysis of intragastric fluid dynamics and drug absorption","volume":"30","author":"Yamashita","year":"2013","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2023.06.002_b0100","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap((\u00ae)) system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0105","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"12","author":"Psachoulias","year":"2011","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2023.06.002_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.xphs.2017.09.002","article-title":"The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene","volume":"107","author":"Tsume","year":"2018","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2010.07.027","article-title":"Computational oral absorption simulation of free base drugs","volume":"398","author":"Sugano","year":"2010","journal-title":"Int J Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1208\/s12248-018-0217-6","article-title":"Measuring the impact of gastrointestinal variables on the systemic outcome of two suspensions of posaconazole by a PBPK model","volume":"20","author":"Hens","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2023.06.002_b0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/AAC.30.2.206","article-title":"Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers","volume":"30","author":"Huang","year":"1986","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.ejpb.2023.06.002_b0130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1021\/mp400465p","article-title":"In vitro-in vivo correlation in the effect of supersaturation on intestinal absorption of BCS class 2 drugs","volume":"11","author":"Higashino","year":"2014","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0135","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.xphs.2019.03.007","article-title":"In Vitro Assessment of Supersaturation\/Precipitation and Biological Membrane Permeation of Poorly Water-Soluble Drugs: A Case Study With Albendazole and Ketoconazole","volume":"108","author":"Kataoka","year":"2019","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0140","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1021\/la0523661","article-title":"Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening","volume":"22","author":"Lindfors","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2023.06.002_b0145","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1021\/acs.analchem.9b01378","article-title":"Direct Measurement of Amorphous Solubility","volume":"91","author":"\u0160tukelj","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2023.06.002_b0150","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1021\/acs.molpharmaceut.1c00480","article-title":"Impact of Simulated Intestinal Fluids on Dissolution, Solution Chemistry, and Membrane Transport of Amorphous Multidrug Formulations","volume":"18","author":"Sayed","year":"2021","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0155","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1021\/acs.molpharmaceut.7b00178","article-title":"Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives","volume":"3","author":"Ueda","year":"2017","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0160","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/jps.23826","article-title":"Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs","volume":"103","author":"Raina","year":"2014","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3897\/pharmacia.67.e50159","article-title":"HPLC-MS\/MS method development for the quantitative determination of nifedipine for Caco-2 permeability assay","volume":"67","author":"Logoyda","year":"2020","journal-title":"Pharmacia"},{"key":"10.1016\/j.ejpb.2023.06.002_b0170","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1021\/acs.molpharmaceut.7b00406","article-title":"Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug","volume":"14","author":"Pathak","year":"2017","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0175","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1208\/s12248-014-9646-z","article-title":"Effect of Excipients on the Particle Size of Precipitated Pioglitazone in the Gastrointestinal Tract : Impact on Bioequivalence","volume":"16","author":"Sugita","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2023.06.002_b0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2016.04.004","article-title":"Characterizing the Dissolution Profiles of Supersaturable Salts, Cocrystals, and Solvates to Enhance In Vivo Oral Absorption","volume":"103","author":"Hisada","year":"2016","journal-title":"Eur J Pharm Biopharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0185","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/jps.24391","article-title":"Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications","volume":"104","author":"Sugano","year":"2015","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.06.002_b0190","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.molpharmaceut.8b00811","article-title":"Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro","volume":"16","author":"Keemink","year":"2019","journal-title":"Mol Pharm."},{"key":"10.1016\/j.ejpb.2023.06.002_b0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejpb.2023.05.016","article-title":"The impact of surface area per volume (SA\/V) ratio on drug transport from supersaturated solutions of ketoconazole","volume":"188","author":"Higashino","year":"2023","journal-title":"Eur J Pharm Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123001509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123001509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:51:53Z","timestamp":1760547113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123001509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"alternative-id":["S0939641123001509"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.06.002","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of degree and duration of supersaturation on in vivo absorption profiles for highly permeable drugs, dipyridamole and ketoconazole","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}